Velasquez, W S <br/><br/>
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysis.  [electronic resource] 

 -  Cancer  May 1994 
 - 2408-16 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/1097-0142(19940501)73:9<2408::aid-cncr2820730926>3.0.co;2-m  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Bleomycin--administration & dosage<br/>Combined Modality Therapy<br/>Cyclophosphamide--administration & dosage<br/>Dexamethasone--administration & dosage<br/>Doxorubicin--administration & dosage<br/>Etoposide--administration & dosage<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>L-Lactate Dehydrogenase--blood<br/>Lymphoma, Non-Hodgkin--drug therapy<br/>Male<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Prednisone--administration & dosage<br/>Prognosis<br/>Radiotherapy Dosage<br/>Remission Induction<br/>Survival Rate<br/>Vincristine--administration & dosage<br/>beta 2-Microglobulin--analysis